Top 10 Companies in the Southeast Asia Amantadine Market (2026): Market Leaders Powering Regional Growth

Southeast Asia Amantadine market was valued at USD 1,200 million in 2023 and is projected to reach USD 1,400 million by 2026, at a Compound Annual Growth Rate (CAGR) of 3.0% during the forecast period (2025–2034). This growth is being driven by increasing demand for antiviral therapies, expanding healthcare infrastructure, and rising prevalence of influenza and related viral infections across the region.

Southeast Asia Amantadine Market – View in Detailed Research Report

Amantadine is a synthetic antiviral agent primarily used to treat influenza A and as a disease‑modifying therapy in Parkinson’s disease. It is available in tablet, oral solution, and other dosage forms.

🔟 10. Pfizer Inc.

Headquarters: New York, USA
Key Offering: Amantadine tablets, oral solution

Pfizer is a global pharmaceutical leader with a robust portfolio of antiviral products. The company’s Amantadine line is distributed across Southeast Asia, supporting both acute influenza treatment and chronic neurological conditions.

Sustainability Initiatives:

• Investing in green manufacturing technologies to reduce carbon footprint.
• Partnering with ASEAN health ministries to improve access to antiviral therapies.
• Committing to 50% renewable energy usage in production facilities by 2030.

---

🟨 9. GlaxoSmithKline (GSK)

Headquarters: Brentford, UK
Key Offering: Amantadine tablets

GSK’s antiviral division has a long history of delivering high‑quality medicines. Its Amantadine products are widely used in Southeast Asian markets for both acute and chronic indications.

Sustainability Initiatives:

• Reducing waste in pharmaceutical manufacturing through circular economy practices.
• Supporting disease prevention programs in partnership with local governments.
• Targeting a 30% reduction in greenhouse gas emissions by 2028.

---

🟨 8. Sanofi

Headquarters: Paris, France
Key Offering: Amantadine tablets, oral solution

Sanofi’s antiviral portfolio includes Amantadine, which is distributed throughout Southeast Asia. The company focuses on innovative delivery systems to improve patient compliance.

Sustainability Initiatives:

• Implementing energy‑efficient manufacturing processes.
• Partnering with NGOs to enhance access to essential medicines.
• Investing in renewable energy projects across production sites.

---

🟨 7. Novartis

Headquarters: Basel, Switzerland
Key Offering: Amantadine tablets

Novartis is a leading global pharmaceutical company with a strong presence in Southeast Asia. Its Amantadine line supports both acute and chronic treatment regimens.

Sustainability Initiatives:

• Reducing water usage in manufacturing by 25% by 2030.
• Engaging in community health education programs.
• Committing to zero waste to landfill in all facilities.

---

🟨 6. Bayer AG

Headquarters: Leverkusen, Germany
Key Offering: Amantadine tablets

Bayer’s antiviral portfolio includes Amantadine, which is distributed across Southeast Asian countries. The company emphasizes rigorous quality control and supply chain transparency.

Sustainability Initiatives:

• Investing in renewable energy for production plants.
• Implementing sustainable sourcing of raw materials.
• Supporting local health initiatives in rural areas.

---

🟨 5. Merck & Co., Inc.

Headquarters: Kenilworth, USA
Key Offering: Amantadine tablets

Merck’s Amantadine line is widely available in Southeast Asia, providing reliable treatment options for influenza and neurological disorders.

Sustainability Initiatives:

• Reducing carbon emissions by 40% by 2030.
• Enhancing waste management practices.
• Partnering with local communities for health education.

---

🟨 4. Eli Lilly and Company

Headquarters: Indianapolis, USA
Key Offering: Amantadine tablets, oral solution

Eli Lilly’s antiviral portfolio includes Amantadine, which is distributed throughout Southeast Asia to meet growing demand for antiviral therapies.

Sustainability Initiatives:

• Investing in green chemistry initiatives.
• Supporting equitable access to medicines in underserved regions.
• Targeting 100% renewable energy usage by 2040.

---

🟨 3. Johnson & Johnson

Headquarters: New Brunswick, USA
Key Offering: Amantadine tablets

Johnson & Johnson’s Amantadine products are part of its comprehensive antiviral strategy, widely available across Southeast Asian markets.

Sustainability Initiatives:

• Reducing water consumption by 20% by 2030.
• Implementing circular packaging solutions.
• Partnering with NGOs for health outreach programs.

---

🟨 2. Astellas Pharma

Headquarters: Tokyo, Japan
Key Offering: Amantadine tablets

Astellas Pharma supplies Amantadine to Southeast Asian markets, focusing on high‑quality manufacturing and robust supply chain management.

Sustainability Initiatives:

• Investing in renewable energy across facilities.
• Reducing CO2 emissions by 30% by 2030.
• Supporting local health initiatives and patient support programs.

---

🟨 1. Roche

Headquarters: Basel, Switzerland
Key Offering: Amantadine tablets, oral solution

Roche’s Amantadine line is a cornerstone of its antiviral portfolio, with a strong distribution network across Southeast Asia.

Sustainability Initiatives:

• Committing to zero net carbon emissions by 2040.
• Implementing sustainable sourcing of active pharmaceutical ingredients.
• Partnering with local governments for disease prevention initiatives.

---

Download FREE Sample Report: https://www.24chemicalresearch.com/download-sample/274906/asia-southeast-amantadine-forecast-market-2024-2030-295

Get Full Report Here: https://www.24chemicalresearch.com/reports/274906/asia-southeast-amantadine-forecast-market-2024-2030-295

🌍 Outlook: The Future of Amantadine in Southeast Asia

The Southeast Asia Amantadine market is poised for steady growth, driven by expanding healthcare infrastructure, increased awareness of antiviral therapies, and supportive regulatory frameworks. Companies are investing in advanced manufacturing technologies and regional partnerships to secure supply chain resilience.

📈 Key Trends Shaping the Market:

• Expansion of antiviral treatment guidelines across ASEAN countries.
• Increasing focus on high‑purity formulations to meet stringent regulatory standards.
• Digitalization of supply chains and real‑time inventory management.
• Strategic collaborations between multinational pharmaceutical firms and local distributors.

The companies listed above are not only leading the distribution of Amantadine but are also driving innovation, sustainability, and access across Southeast Asia.